Oncology

The funding will be used to increase the adoption of the company's first-in-class multi-cancer early detection test, OncoK9.

In a dvm360® interview, Sue Ettinger, DVM, DACVIM (Oncology), shared the types of lymphoma and common signs to be mindful of surrounding this condition.

Despite all the advancements in human medicine over the past few decades, veterinary medicine has seen little change until recently. Now, several new therapeutic developments have emerged specifically for use in veterinary medicine that have promising potential in changing how veterinarians treat cancer.

Jenny Fisher, RVT, VTS, outlined the B.A.G. acronym and how it is useful in identifying the body systems affected by chemotherapy and radiation.

Sue Ettinger, DVM, DACVIM (Oncology), disclosed one thing she wants veterinary professionals to know about being an oncology veterinarian, plus shares the benefits one of her patients experienced on chemotherapy.

Check out this week's highlights.

In this video interview with dvm360®, Jenny Fisher, RVT, VTS, reviewed several ways veterinary professionals are treating their patients with cancer.

The case for an increased focus on research at the overlapping boundaries between human and animal health in the area of heart disease.

A sneak peek of this week's headlines.

In a recent dvm360® interview, Jenny Fisher, RVT, VTS, explains 2 common techniques when performing fine needle aspirations and when each is appropriate to use.

As part of National Pet Cancer Awareness Month in November, Nationwide is engaging claims data to offer unique analyses and pledging support for pet cancer research.

During a dvm360® interview, Jenny Fisher, RVT, VTS, discussed the variations between how these tumor types present themselves in both dogs and cats.

At New York Vet Show 2021, Heidi Lobprise, DVM, DAVDC, shared her insights on oral pain and pain management.

These insightful articles highlight the modern diagnostic and treatment measures for feline and canine MCTs.

The program will be a part of the NCI’s “comprehensive” Cancer Center designation renewal.

Funding will go towards a Canada-based researcher studying early detection and/or prevention of canine cancer to achieve better outcomes for dogs impacted by this disease.

In a recent interview with dvm360®, Dr Ettinger outlines various tips and tricks for diagnosing and treating MCTs in dogs.

Sue Ettinger, DVM, DACVIM (Oncology) discussed innovations in canine cancer treatment during a keynote address at the Atlantic Coast Veterinary Conference.

A novel immunotherapy for dogs with osteosarcoma is discussed.

Sue Ettinger, DVM, DACVIM (Oncology)—known as Dr Sue Cancer Vet—discusses recent advancements in cancer testing for canines. The highlights include 2 new low-cost, noninvasive tests.

In an interview with dvm360®, Sue Ettinger, DVM, DACVIM (Oncology)—known as Dr Sue Cancer Vet—discusses reasons why some pet owners decline to have their dogs provided with treatment for lymphoma and how veterinarians can help clients address these challenges.

Anivive Lifesciences Inc Founder, CEO and Chairman Dylan Balsz discussed the company’s mission and how it is working to serve unmet needs in veterinary health.

In an interview with dvm360®, Sue Ettinger, DVM, DACVIM (Oncology)—Dr Sue Cancer Vet—offers insight about what to tell pet owners when their dog has been diagnosed with lymphoma.

Anivive Lifesciences' Chief Commerical Officer Chad Todd, DVM, offers insight on Laverdia-CA1, the first conditionally approved oral treatment for canine lymphoma.